Results
1 -
1 of
1
(Click
here to explore results)
- New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. Mohammed M. Alanazi, Hazem Elkady, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Manal M. Alanazi, Madhawi A. Alharbi, Ibrahim H. Eissa, Mohammed A. Dahab
, RSC Adv.
, 2021
, 11
, 30315